Cargando…

Formulation and In vitro Interaction of Rhodamine-B Loaded PLGA Nanoparticles with Cardiac Myocytes

This study aims to characterize rhodamine B (Rh B) loaded poly(D,L-lactide-co-glycolide; PLGA) nanoparticles (NPs) and their interactions with cardiac myocytes. PLGA NPs were formulated using single emulsion solvent evaporation technique. The influence of varying parameters such as the stabilizer co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jonderian, Antranik, Maalouf, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138196/ https://www.ncbi.nlm.nih.gov/pubmed/27999542 http://dx.doi.org/10.3389/fphar.2016.00458

Ejemplares similares

Drug-loaded PEG-PLGA nanoparticles for cancer treatment
por: Zhang, Dan, et al.
Publicado: (2022)

mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2021)

Pattern and time course of rhodamine-actin incorporation in cardiac myocytes
Publicado: (1983)

Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading
por: Han, Felicity Y., et al.
Publicado: (2016)

Synthesis and appraisal of dalbergin-loaded PLGA nanoparticles modified with galactose against hepatocellular carcinoma: In-vitro, pharmacokinetic, and in-silico studies
por: Gautam, Anurag Kumar, et al.
Publicado: (2022)

Formulation and Evaluation of Pravastatin Sodium-Loaded PLGA Nanoparticles: In vitro–in vivo Studies Assessment
por: Elsayed, Seham I, et al.
Publicado: (2023)

Mechanism of miR-30b-5p-Loaded PEG-PLGA Nanoparticles for Targeted Treatment of Heart Failure
por: Ren, Yu, et al.
Publicado: (2021)

Red Blood Cell Membrane-Camouflaged PLGA Nanoparticles Loaded With Basic Fibroblast Growth Factor for Attenuating Sepsis-Induced Cardiac Injury
por: Li, Xinze, et al.
Publicado: (2022)

PLGA-Based Nanoparticles in Cancer Treatment
por: Rezvantalab, Sima, et al.
Publicado: (2018)

5-Fluorouracil-Loaded PLGA Nanoparticles: Formulation, Physicochemical Characterisation, and In VitroAnti-Cancer Activity
por: Gahtani, Reem M., et al.
Publicado: (2023)

Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
por: Hill, Marcus, et al.
Publicado: (2019)

Preparation and Release Profiles in Vitro/Vivo of Galantamine Pamoate Loaded Poly (Lactideco-Glycolide) (PLGA) Microspheres
por: Du, Liping, et al.
Publicado: (2021)

Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment
por: Bao, Shihui, et al.
Publicado: (2021)

Curcumin-Loaded mPEG-PLGA Nanoparticles Attenuates the Apoptosis and Corticosteroid Resistance Induced by Cigarette Smoke Extract
por: Chen, Xi, et al.
Publicado: (2022)

Formulation, Colloidal Characterization, and In Vitro Biological Effect of BMP-2 Loaded PLGA Nanoparticles for Bone Regeneration
por: del Castillo-Santaella, Teresa, et al.
Publicado: (2019)

Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
por: Lee, Young-Ran, et al.
Publicado: (2011)

Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
por: Busari, Zulaikha A., et al.
Publicado: (2017)

Simvastatin Promotes Cardiac Myocyte Relaxation in Association with Phosphorylation of Troponin I
por: MacDougall, David A., et al.
Publicado: (2017)

Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
por: Hu, Sanyuan, et al.
Publicado: (2010)

Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment
por: Chen, Xiao-ping, et al.
Publicado: (2019)

Calcium and IP3 dynamics in cardiac myocytes: experimental and computational perspectives and approaches
por: Hohendanner, Felix, et al.
Publicado: (2014)

Variable in Vivo and in Vitro Biological Effects of Cerium Oxide Nanoparticle Formulations
por: Heckman, Karin L., et al.
Publicado: (2020)

Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells
por: Ibrahim, Wisam Nabeel, et al.
Publicado: (2020)

Antileishmanial Activity of Amphotericin B-loaded-PLGA Nanoparticles: An Overview
por: Palma, Ernesto, et al.
Publicado: (2018)

In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles
por: Shi, Lei, et al.
Publicado: (2013)

Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics
por: Ünal, Sedat, et al.
Publicado: (2022)

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
por: Sánchez-López, Elena, et al.
Publicado: (2018)

The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo
por: Li, Zhenbao, et al.
Publicado: (2017)

Formulation and Characterization of Ciprofloxacin loaded PLGA Microspheres for Applications in Orthopedic Infections
por: MOCANU, ANDREEA-GABRIELA, et al.
Publicado: (2017)

Formulation development of lipid polymer hybrid nanoparticles of doxorubicin and its in-vitro, in-vivo and computational evaluation
por: Shafique, Muhammad, et al.
Publicado: (2023)

Tuning the structural properties of cadmium–aluminum layered double hydroxide for enhanced photocatalytic dye degradation
por: Saliba, Daniel, et al.
Publicado: (2020)

Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration
por: Wang, Siqi, et al.
Publicado: (2022)

Docetaxel Loaded PEG-PLGA Nanoparticles: Optimized Drug Loading, In-vitro Cytotoxicity and In-vivo Antitumor Effect
por: Noori Koopaei, Mona, et al.
Publicado: (2014)

PLGA: the smart therapeutics goods carrier
por: Poojari, Radhika J.
Publicado: (2013)

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
por: Rafiei, Pedram, et al.
Publicado: (2017)

Reduced Cardiotoxicity of Ponatinib-Loaded PLGA-PEG-PLGA Nanoparticles in Zebrafish Xenograft Model
por: Al-Thani, Hissa F., et al.
Publicado: (2022)

Formulation of Liver-Specific PLGA-DY-635 Nanoparticles Loaded with the Protein Kinase C Inhibitor Bisindolylmaleimide I
por: Shkodra, Blerina, et al.
Publicado: (2020)

In Vitro, Ex Vivo, and In Vivo Evaluation of Nanoparticle-Based Topical Formulation Against Candida albicans Infection
por: Sadozai, Sajid Khan, et al.
Publicado: (2022)

In Vitro Cytotoxicity of Oleanolic/Ursolic Acids-Loaded in PLGA Nanoparticles in Different Cell Lines
por: Silva, Amélia M., et al.
Publicado: (2019)

Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice
por: Liang, Qiuzhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_trtn3rlp4peaib88m281qm0mm2